Search Results - "St Rose, Earl" :: K.UTB vyhledávací portál | TBU Library Retrieval Portal

Triple Inhaled Therapy at Two Glucocorticoid Doses in Moderate-to-Very-Severe COPD

Triple Inhaled Therapy at Two Glucocorticoid Doses in Moderate-to-Very-Severe COPD

by Rabe, Klaus F, Martinez, Fernando J, Ferguson, Gary T, Wang, Chen, Singh, Dave, Wedzicha, Jadwiga A, Trivedi, Roopa, St. Rose, Earl, Ballal, Shaila, McLaren, Julie, Darken, Patrick, Aurivillius, Magnus, Reisner, Colin, Dorinsky, Paul
Published in The New England journal of medicine (02.07.2020)

Get full text

Journal Article

Reduced All-Cause Mortality in the ETHOS Trial of Budesonide/Glycopyrrolate/Formoterol for Chronic Obstructive Pulmonary Disease. A Randomized, Double-Blind, Multicenter, Parallel-Group Study

Reduced All-Cause Mortality in the ETHOS Trial of Budesonide/Glycopyrrolate/Formoterol for Chronic Obstructive Pulmonary Disease. A Randomized, Double-Blind, Multicenter, Parallel-Group Study

by Martinez, Fernando J, Rabe, Klaus F, Ferguson, Gary T, Wedzicha, Jadwiga A, Singh, Dave, Wang, Chen, Rossman, Kimberly, St Rose, Earl, Trivedi, Roopa, Ballal, Shaila, Darken, Patrick, Aurivillius, Magnus, Reisner, Colin, Dorinsky, Paul
Published in American journal of respiratory and critical care medicine (01.03.2021)

Get full text

Journal Article

A randomized, seven-day study to assess the efficacy and safety of a glycopyrrolate/formoterol fumarate fixed-dose combination metered dose inhaler using novel Co-Suspension™ Delivery Technology in patients with moderate-to-very severe chronic obstructive pulmonary disease

A randomized, seven-day study to assess the efficacy and safety of a glycopyrrolate/formoterol fumarate fixed-dose combination metered dose inhaler using novel Co-Suspension™ Delivery Technology in patients with moderate-to-very severe chronic obstructive pulmonary disease

by Reisner, Colin, Fabbri, Leonardo M, Kerwin, Edward M, Fogarty, Charles, Spangenthal, Selwyn, Rabe, Klaus F, Ferguson, Gary T, Martinez, Fernando J, Donohue, James F, Darken, Patrick, St Rose, Earl, Orevillo, Chad, Strom, Shannon, Fischer, Tracy, Golden, Michael, Dwivedi, Sarvajna
Published in Respiratory research (06.01.2017)

Get full text

Journal Article

An Open-Label Study Evaluating the Performance of the Dose Indicator in a Metered Dose Inhaler Delivering Glycopyrrolate and Formoterol Fumarate in Patients with Moderate-to-Very Severe Chronic Obstructive Pulmonary Disease

An Open-Label Study Evaluating the Performance of the Dose Indicator in a Metered Dose Inhaler Delivering Glycopyrrolate and Formoterol Fumarate in Patients with Moderate-to-Very Severe Chronic Obstructive Pulmonary Disease

by Pudi, Krishna, Feldman, Gregory, Fakih, Faisal, Mack, Peter, Maes, Andrea, Siddiqui, Shahid, St Rose, Earl, Reisner, Colin
Published in Journal of aerosol medicine and pulmonary drug delivery (01.02.2019)

Get full text

Journal Article

24-h bronchodilation and inspiratory capacity improvements with glycopyrrolate/formoterol fumarate via co-suspension delivery technology in COPD

24-h bronchodilation and inspiratory capacity improvements with glycopyrrolate/formoterol fumarate via co-suspension delivery technology in COPD

by Reisner, Colin, Gottschlich, Gregory, Fakih, Faisal, Koser, Andras, Krainson, James, Delacruz, Luis, Arora, Samir, Feldman, Gregory, Pudi, Krishna, Siddiqui, Shahid, Orevillo, Chad, Maes, Andrea, St Rose, Earl, Martin, Ubaldo
Published in Respiratory research (18.08.2017)

Get full text

Journal Article

Functional respiratory imaging assessment of glycopyrrolate and formoterol fumarate metered dose inhalers formulated using co-suspension delivery technology in patients with COPD

Functional respiratory imaging assessment of glycopyrrolate and formoterol fumarate metered dose inhalers formulated using co-suspension delivery technology in patients with COPD

by De Backer, Wilfried, De Backer, Jan, Verlinden, Ilse, Leemans, Glenn, Van Holsbeke, Cedric, Mignot, Benjamin, Jenkins, Martin, Griffis, Dianne, Ivanov, Stefan, Fitzpatrick, Jane, St Rose, Earl, Martin, Ubaldo J., Reisner, Colin
Published in Therapeutic advances in respiratory disease (2020)

Get full text

Journal Article

Randomized, double-blind, placebo-controlled trial to assess the efficacy and safety of three doses of co-suspension delivery technology glycopyrronium MDI in Japanese patients with moderate-to-severe COPD

Randomized, double-blind, placebo-controlled trial to assess the efficacy and safety of three doses of co-suspension delivery technology glycopyrronium MDI in Japanese patients with moderate-to-severe COPD

by Fukushima, Yasushi, Nakatani, Yuji, Ide, Yumiko, Sekino, Hisakuni, St Rose, Earl, Siddiqui, Shahid, Maes, Andrea, Reisner, Colin
Published in International journal of chronic obstructive pulmonary disease (01.01.2018)

Get full text

Journal Article

Efficacy, safety, and pharmacokinetics of budesonide/formoterol fumarate delivered via metered dose inhaler using innovative co-suspension delivery technology in patients with moderate-to-severe COPD

Efficacy, safety, and pharmacokinetics of budesonide/formoterol fumarate delivered via metered dose inhaler using innovative co-suspension delivery technology in patients with moderate-to-severe COPD

by Kerwin, Edward M, Siler, Thomas M, Arora, Samir, Darken, Patrick, Rose, St, Earl, Reisner, Colin
Published in International journal of chronic obstructive pulmonary disease (01.01.2018)

Get full text

Journal Article

Erratum to: A randomized, seven-day study to assess the efficacy and safety of a glycopyrrolate/formoterol fumarate fixed-dose combination metered dose inhaler using novel Co-Suspension™ Delivery Technology in patients with moderate-to-very severe chronic obstructive pulmonary disease

Erratum to: A randomized, seven-day study to assess the efficacy and safety of a glycopyrrolate/formoterol fumarate fixed-dose combination metered dose inhaler using novel Co-Suspension™ Delivery Technology in patients with moderate-to-very severe chronic obstructive pulmonary disease

by Reisner, Colin, Fabbri, Leonardo M, Kerwin, Edward M, Fogarty, Charles, Spangenthal, Selwyn, Rabe, Klaus F, Ferguson, Gary T, Martinez, Fernando J, Donohue, James F, Darken, Patrick, St Rose, Earl, Orevillo, Chad, Strom, Shannon, Fischer, Tracy, Golden, Michael, Dwivedi, Sarvajna
Published in Respiratory research (21.08.2017)

Get full text

Journal Article

A phase IIb randomized, chronic-dosing, incomplete block, cross-over study of glycopyrronium, delivered via metered dose inhaler, compared with a placebo and an active control in patients with moderate-to-severe COPD

A phase IIb randomized, chronic-dosing, incomplete block, cross-over study of glycopyrronium, delivered via metered dose inhaler, compared with a placebo and an active control in patients with moderate-to-severe COPD

by Kerwin, Edward M, Spangenthal, Selwyn, Kollar, Christine, St Rose, Earl, Reisner, Colin
Published in Respiratory research (05.03.2018)

Get full text

Journal Article

A multicenter, randomized, double-blind dose-ranging study of glycopyrrolate/formoterol fumarate fixed-dose combination metered dose inhaler compared to the monocomponents and open-label tiotropium dry powder inhaler in patients with moderate-to-severe COPD

A multicenter, randomized, double-blind dose-ranging study of glycopyrrolate/formoterol fumarate fixed-dose combination metered dose inhaler compared to the monocomponents and open-label tiotropium dry powder inhaler in patients with moderate-to-severe COPD

by Tashkin, Donald P, Martinez, Fernando J, Rodriguez-Roisin, Roberto, Fogarty, Charles, Gotfried, Mark, Denenberg, Michael, Gottschlich, Gregory, Donohue, James F, Orevillo, Chad, Darken, Patrick, Rose, Earl St, Strom, Shannon, Fischer, Tracy, Golden, Michael, Reisner, Colin
Published in Respiratory medicine (01.11.2016)

Get full text

Journal Article

Dose-response to inhaled glycopyrrolate delivered with a novel Co-Suspension™ Delivery Technology metered dose inhaler (MDI) in patients with moderate-to-severe COPD

Dose-response to inhaled glycopyrrolate delivered with a novel Co-Suspension™ Delivery Technology metered dose inhaler (MDI) in patients with moderate-to-severe COPD

by Fabbri, Leonardo M, Kerwin, Edward M, Spangenthal, Selwyn, Ferguson, Gary T, Rodriguez-Roisin, Roberto, Pearle, James, Sethi, Sanjay, Orevillo, Chad, Darken, Patrick, St Rose, Earl, Fischer, Tracy, Golden, Michael, Dwivedi, Sarvajna, Reisner, Colin
Published in Respiratory research (02.09.2016)

Get full text

Journal Article

Corrigendum to “A multicenter, randomized, double-blind dose-ranging study of glycopyrrolate/formoterol fumarate fixed-dose combination metered dose inhaler compared to the monocomponents and open-label tiotropium dry powder inhaler in patients with moderate-to-severe COPD” [Respir. Med. 120 November 2016 16–24]

Corrigendum to “A multicenter, randomized, double-blind dose-ranging study of glycopyrrolate/formoterol fumarate fixed-dose combination metered dose inhaler compared to the monocomponents and open-label tiotropium dry powder inhaler in patients with moderate-to-severe COPD” [Respir. Med. 120 November 2016 16–24]

by Tashkin, Donald P., Martinez, Fernando J., Rodriguez-Roisin, Roberto, Fogarty, Charles, Gotfried, Mark, Denenberg, Michael, Gottschlich, Gregory, Donohue, James F., Orevillo, Chad, Darken, Patrick, St Rose, Earl, Strom, Shannon, Fischer, Tracy, Golden, Michael, Reisner, Colin
Published in Respiratory medicine (01.08.2017)

Get full text

Journal Article

Randomized study of the safety, pharmacokinetics, and bronchodilatory efficacy of a proprietary glycopyrronium metered-dose inhaler in study patients with chronic obstructive pulmonary disease

Randomized study of the safety, pharmacokinetics, and bronchodilatory efficacy of a proprietary glycopyrronium metered-dose inhaler in study patients with chronic obstructive pulmonary disease

by Rennard, Stephen, Fogarty, Charles, Reisner, Colin, Fernandez, Carlos, Fischer, Tracy, Golden, Michael, Rose, Earl St, Darken, Patrick, Tardie, Gregory, Orevillo, Chadwick
Published in BMC pulmonary medicine (16.07.2014)

Get full text

Journal Article

Corrigendum to “A randomized study of formoterol fumarate in a porous particle metered-dose inhaler in patients with moderate-to-severe COPD” [Resp Med 108 (2014) 1327–1335]

Corrigendum to “A randomized study of formoterol fumarate in a porous particle metered-dose inhaler in patients with moderate-to-severe COPD” [Resp Med 108 (2014) 1327–1335]

by Quinn, Dean, Seale, J.P, Reisner, Colin, Fischer, Tracy, Golden, Michael, Fernandez, Carlos, Darken, Patrick, St. Rose, Earl, Thomas, Mervyn, Tardie, Gregory, Orevillo, Chadwick
Published in Respiratory medicine (01.10.2015)

Get full text

Journal Article

Efficacy and safety of four doses of glycopyrrolate/formoterol fumarate delivered via a metered dose inhaler compared with the monocomponents in patients with moderate-to-severe COPD

Efficacy and safety of four doses of glycopyrrolate/formoterol fumarate delivered via a metered dose inhaler compared with the monocomponents in patients with moderate-to-severe COPD

by Reisner, Colin, Pearle, James, Kerwin, Edward M, Rose, Earl St, Darken, Patrick
Published in International journal of chronic obstructive pulmonary disease (01.01.2018)

Get full text

Journal Article

Efficacy of Formoterol Fumarate Delivered by Metered Dose Inhaler Using Co-Suspension™ Delivery Technology Versus Foradil® Aerolizer® in Moderate-To-Severe COPD: A Randomized, Dose-Ranging Study

Efficacy of Formoterol Fumarate Delivered by Metered Dose Inhaler Using Co-Suspension™ Delivery Technology Versus Foradil® Aerolizer® in Moderate-To-Severe COPD: A Randomized, Dose-Ranging Study

by Sethi, Sanjay, Fogarty, Charles, Hanania, Nicola A, Martinez, Fernando J, Rennard, Stephen, Fries, Michael, Orevillo, Chad, Darken, Patrick, St Rose, Earl, Strom, Shannon, Fischer, Tracy, Golden, Michael, Dwivedi, Sarvajna, Reisner, Colin
Published in Chronic obstructive pulmonary diseases (17.11.2016)

Get full text

Journal Article

The pharmacokinetics of three doses of budesonide/glycopyrronium/formoterol fumarate dihydrate metered dose inhaler compared with active controls: A Phase I randomized, single-dose, crossover study in healthy adults

The pharmacokinetics of three doses of budesonide/glycopyrronium/formoterol fumarate dihydrate metered dose inhaler compared with active controls: A Phase I randomized, single-dose, crossover study in healthy adults

by Darken, Patrick, DePetrillo, Paolo, Reisner, Colin, St Rose, Earl, Dorinsky, Paul
Published in Pulmonary pharmacology & therapeutics (01.06.2018)

Get full text

Journal Article

A phase III study of triple therapy with budesonide/glycopyrrolate/formoterol fumarate metered dose inhaler 320/18/9.6 μg and 160/18/9.6 μg using co-suspension delivery technology in moderate-to-very severe COPD: The ETHOS study protocol

A phase III study of triple therapy with budesonide/glycopyrrolate/formoterol fumarate metered dose inhaler 320/18/9.6 μg and 160/18/9.6 μg using co-suspension delivery technology in moderate-to-very severe COPD: The ETHOS study protocol

by Rabe, Klaus F., Martinez, Fernando J., Ferguson, Gary T., Wang, Chen, Singh, Dave, Wedzicha, Jadwiga A., Trivedi, Roopa, St Rose, Earl, Ballal, Shaila, McLaren, Julie, Darken, Patrick, Reisner, Colin, Dorinsky, Paul
Published in Respiratory medicine (01.10.2019)

Get full text

Journal Article

Randomized dose-ranging study of a budesonide metered-dose inhaler by using co-suspension delivery technology in asthma

Randomized dose-ranging study of a budesonide metered-dose inhaler by using co-suspension delivery technology in asthma

by Miller, S David, Nyberg, Jack, Siddiqui, Shahid, Dorinsky, Paul, St Rose, Earl, Reisner, Colin
Published in Allergy and asthma proceedings (23.09.2018)

Get more information

Journal Article